Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Journal of the National Comprehensive Cancer Network : JNCCN|May 19, 2017
Smoking Cessation in Patients With Cancer: Treatment Advances and the Oncologist's RolePaul CinciripiniNicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 19, 2004
A meta-analytic review of the CYP2A6 genotype and smoking behaviorBrian Carter, Tracy Long, Paul CinciripiniNature Genetics|April 30, 2010
Chipping away at the genetics of smoking behaviorChristopher I Amos, Margaret R Spitz, Paul CinciripiniClinical Journal of Oncology Nursing|April 4, 2015
Selection of optimal tobacco cessation medication treatment in patients with cancerRosario Wippold, Maher Karam-Hage, Janice Blalock, et al.Behavior Genetics|October 21, 2009
The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controlsJessica Clague, Paul Cinciripini, Janice Blalock, et al.Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|October 16, 2019
Socioeconomic Status, Social Context, and Smoking Lapse During a Quit Attempt: An Ecological Momentary Assessment StudyChristopher Cambron, Cho Y Lam, Paul Cinciripini, et al.Biometrics|March 20, 2015
Bayesian function-on-function regression for multilevel functional dataMark J Meyer, Brent A Coull, Francesco Versace, et al.Drug and Alcohol Dependence|February 15, 2020
Socioeconomic status, mindfulness, and momentary associations between stress and smoking lapse during a quit attemptChristopher Cambron, Patricia Hopkins, Cassidy Burningham, et al.Psychopharmacology|January 10, 2014
The relationship between the nicotine metabolite ratio and three self-report measures of nicotine dependence across sex and raceRobert A Schnoll, Tony P George, Larry Hawk, et al.Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 19, 2004
The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on moodPaul Cinciripini, David Wetter, Gail Tomlinson, et al.Pageof 4